Serum matrix metalloproteinase-7 levels in infants with cholestasis and biliary atresia
Abstract Background The aim of this study was to evaluate the serum level of matrix metalloproteinase 7 (MMP7) in infants with cholestasis and the diagnostic values of this biomarker to differentiate biliary atresia (BA) from other causes of cholestasis. Methods This multi-center study is conducted during 2 years in Mofid children’s hospital and Children’s Medical Center, Pediatrics Center of Excellence Tehran, Iran. 54 infants with cholestasis were enrolled in this study with a control group consists of 41 healthy infants with the same age. Serum samples were taken from all these patients to assess serum levels of MMP7, Gamma-glutamyl Transferase (GGT). For each biomarker, we calculated the sensitivity and specificity and other statistical characteristics. Results There were 89 subjects, 22 patients with BA, 32 patients with non-BA cholestasis and 41 subjects as control group. The mean serum MMP7 levels in BA, non-BA cholestasis and control group was 15.91 ng/ml ± 6.64, 4.73 ng/ml ± 2.59 and 0.49 ng/ml ± 0.33, respectively. The best cut-off point is calculated 7.8 ng/ml for MMP7 and 434.5 U/L for GGT. The area under curve (AUC) for these two markers are 0.988 ± 0.008 and 0.854 ± 0.052, respectively. The sensitivity and specificity of MMP7 to differentiate biliary atresia from nonbiliary atresia cholestasis in our study was 95.5% and 94.5%, respectively. The sensitivity and specificity of GGT was 77.3% and 77.8%, respectively. These results show that the MMP7 has more sensitivity and specificity in differentiation. Conclusion MMP7 demonstrated good accuracy to differentiate biliary atresia from other causes of cholestasis..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
BMC Pediatrics - 22(2022), 1, Seite 10 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pejman Rohani [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1186/s12887-022-03409-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ044037848 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ044037848 | ||
| 003 | DE-627 | ||
| 005 | 20230308075532.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12887-022-03409-9 |2 doi | |
| 035 | |a (DE-627)DOAJ044037848 | ||
| 035 | |a (DE-599)DOAJ4665cd8e892e41f1aac3c80139e1719d | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RJ1-570 | |
| 100 | 0 | |a Pejman Rohani |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Serum matrix metalloproteinase-7 levels in infants with cholestasis and biliary atresia |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background The aim of this study was to evaluate the serum level of matrix metalloproteinase 7 (MMP7) in infants with cholestasis and the diagnostic values of this biomarker to differentiate biliary atresia (BA) from other causes of cholestasis. Methods This multi-center study is conducted during 2 years in Mofid children’s hospital and Children’s Medical Center, Pediatrics Center of Excellence Tehran, Iran. 54 infants with cholestasis were enrolled in this study with a control group consists of 41 healthy infants with the same age. Serum samples were taken from all these patients to assess serum levels of MMP7, Gamma-glutamyl Transferase (GGT). For each biomarker, we calculated the sensitivity and specificity and other statistical characteristics. Results There were 89 subjects, 22 patients with BA, 32 patients with non-BA cholestasis and 41 subjects as control group. The mean serum MMP7 levels in BA, non-BA cholestasis and control group was 15.91 ng/ml ± 6.64, 4.73 ng/ml ± 2.59 and 0.49 ng/ml ± 0.33, respectively. The best cut-off point is calculated 7.8 ng/ml for MMP7 and 434.5 U/L for GGT. The area under curve (AUC) for these two markers are 0.988 ± 0.008 and 0.854 ± 0.052, respectively. The sensitivity and specificity of MMP7 to differentiate biliary atresia from nonbiliary atresia cholestasis in our study was 95.5% and 94.5%, respectively. The sensitivity and specificity of GGT was 77.3% and 77.8%, respectively. These results show that the MMP7 has more sensitivity and specificity in differentiation. Conclusion MMP7 demonstrated good accuracy to differentiate biliary atresia from other causes of cholestasis. | ||
| 650 | 4 | |a MMP7 | |
| 650 | 4 | |a GGT | |
| 650 | 4 | |a Biliary atresia | |
| 650 | 4 | |a Alkaline phosphatase | |
| 653 | 0 | |a Pediatrics | |
| 700 | 0 | |a Seyyed Bahador Mirrahimi |e verfasserin |4 aut | |
| 700 | 0 | |a Haleh Bashirirad |e verfasserin |4 aut | |
| 700 | 0 | |a Parisa Rahmani |e verfasserin |4 aut | |
| 700 | 0 | |a Niyoosha Kamran |e verfasserin |4 aut | |
| 700 | 0 | |a Hosein Alimadadi |e verfasserin |4 aut | |
| 700 | 0 | |a Mahmoud Hajipour |e verfasserin |4 aut | |
| 700 | 0 | |a Mohammad Hassan Sohouli |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t BMC Pediatrics |d BMC, 2003 |g 22(2022), 1, Seite 10 |w (DE-627)DOAJ000072729 |x 14712431 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2022 |g number:1 |g pages:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12887-022-03409-9 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/4665cd8e892e41f1aac3c80139e1719d |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12887-022-03409-9 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1471-2431 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2022 |e 1 |h 10 | ||